Latest | F'cast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | n/a | n/a |
ROCE | n/a |
Latest | F'cast | |
---|---|---|
P/E | n/a | n/a |
PEG | n/a | n/a |
Pr/Revenue | n/a | n/a |
Pr/Book | n/a |
Latest | F'cast | |
---|---|---|
Revenue | n/a | n/a |
PBT | n/a | n/a |
EPS | n/a | n/a |
DPS | n/a | n/a |
Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-16 | 216.08 | (47.36) | 2.00¢ | 139.8 | n/a | n/a | n/a | 0.0% |
31-Dec-17 | 241.20 | (53.54) | (4.30)¢ | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-18 | 214.11 | (86.65) | (1.10)¢ | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-19 | 204.89 | (141.10) | (16.00)¢ | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-20 | 227.98 | (189.73) | (18.00)¢ | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Notice of Results | 31-Jan-2023 | 08:30 | RNS |
License to Takeda for Fruquintinib outside China | 23-Jan-2023 | 08:00 | RNS |
Inclusion of ORPATHYS in NRDL in China | 18-Jan-2023 | 14:30 | RNS |
Chinese medicine firm employs Cambridge Universi... | 23-Dec-2009 | Guardian |
Joint venture offers food for growth | 09-Oct-2009 | The Scotsman |
Chi-Med unveils maiden profit | 31-Jul-2009 | The Scotsman |
No deals were found in the last 28 days.
Currency | UK Pounds |
Share Price | 284.00p |
Change Today | -14.00p |
% Change | -4.70 % |
52 Week High | 416.50 |
52 Week Low | 134.50 |
Volume | 15,657 |
Shares Issued | 864.78m |
Market Cap | £2,455.96m |
RiskGrade | 226 |
Value | ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
Time | Volume / Share Price |
09:33 | 3,000 @ 280.08p |
09:33 | 500 @ 284.00p |
09:33 | 3,000 @ 284.00p |
09:33 | 500 @ 284.50p |
09:33 | 500 @ 285.00p |
You are here: research